0001628280-21-015647.txt : 20210804
0001628280-21-015647.hdr.sgml : 20210804
20210804200130
ACCESSION NUMBER: 0001628280-21-015647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy Matthew B.
CENTRAL INDEX KEY: 0001865778
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 211145810
MAIL ADDRESS:
STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC.
STREET 2: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_162812167372819.xml
FORM 4
X0306
4
2021-06-14
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001865778
Murphy Matthew B.
C/O NAUTILUS BIOTECHNOLOGY, INC.
425 PONTIUS AVE N, STE 202
SEATTLE
WA
98109
0
1
0
0
General Counsel
Stock Option (Right to Buy)
10.1
2021-06-14
4
A
0
326526
0
A
2031-06-14
Common Stock
326526.0
326526
D
Subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan), 25% of the shares subject to such Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date (as defined below), and the balance of the shares subject to such Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary. The Vesting Commencement Date is April 1, 2021.
/s/ Matthew B. Murphy
2021-08-04